Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Abstral
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Abstral 100microgram sublingual tablets
0407020A0BJAAAW
|
Abstral | Fentanyl | Central Nervous System | 1,035 |
|
Abstral 200microgram sublingual tablets
0407020A0BJABAX
|
Abstral | Fentanyl | Central Nervous System | 561 |
|
Abstral 400microgram sublingual tablets
0407020A0BJADAZ
|
Abstral | Fentanyl | Central Nervous System | 212 |
|
Abstral 300microgram sublingual tablets
0407020A0BJACAY
|
Abstral | Fentanyl | Central Nervous System | 87 |
|
Abstral 800microgram sublingual tablets
0407020A0BJAFBB
|
Abstral | Fentanyl | Central Nervous System | 67 |
|
Abstral 600microgram sublingual tablets
0407020A0BJAEBA
|
Abstral | Fentanyl | Central Nervous System | 66 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.